Simplex Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Simplex Trading’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54	Closed	-$1K	–	11178
2022 Q2	$1K	Sell	54 -9	-14%	-$281	﹤0.01%	9746
2022 Q1	$2K	Buy	+63	New	+$2.7K	﹤0.01%	9978
2021 Q4	–	Sell	-249	Closed	-$19K	–	11715
2021 Q3	$19K	Hold	249	–	–	﹤0.01%	8497
2021 Q2	$19K	Buy	249 +234	+1,560%	+$14.3K	﹤0.01%	8650
2021 Q1	$97K	Buy	+15	New	+$1.17K	﹤0.01%	5796
2019 Q3	–	Sell	-1	Closed	-$8K	–	8063
2019 Q2	$8K	Hold	1	–	–	﹤0.01%	6255
2019 Q1	$13K	Sell	1 -1	-50%	-$193	﹤0.01%	6011
2018 Q4	$28K	Sell	2 -5	-71%	-$959	﹤0.01%	5064
2018 Q3	$166K	Buy	+7	New	+$1.66K	﹤0.01%	3868
2018 Q2	–	Sell	-1	Closed	-$268	–	6745
2018 Q1	$1K	Buy	+1	New	+$262	﹤0.01%	5859
2017 Q4	–	Hold	0	–	–	–	5706
2017 Q3	–	Sell	-2	Closed	-$4K	–	6835
2017 Q2	$4K	Buy	+2	New	+$599	﹤0.01%	4834
2016 Q4	–	Hold	0	–	-$4K	–	6713
2016 Q3	–	Sell	-1	Closed	-$208	–	4538
2016 Q2	$15K	Buy	+1	New	+$461	﹤0.01%	3192
2015 Q2	–	Hold	0	–	-$2K	–	6016
2015 Q1	–	Hold	0	–	–	–	4232

Other funds holding DMK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Simplex Trading's DMK Position: Q2 2023 in Review

Simplex Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 128 shares — an estimated $1K sold.

Simplex Trading first reported a position in DMK in Q1 2015 and held it in 14 quarters. The position peaked at $133K in Q3 2017. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

Simplex Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 128 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1K.
Simplex Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 14 quarters.
Simplex Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $133K in Q3 2017.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.